CO6430490A2 - Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral - Google Patents

Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Info

Publication number
CO6430490A2
CO6430490A2 CO11126599A CO11126599A CO6430490A2 CO 6430490 A2 CO6430490 A2 CO 6430490A2 CO 11126599 A CO11126599 A CO 11126599A CO 11126599 A CO11126599 A CO 11126599A CO 6430490 A2 CO6430490 A2 CO 6430490A2
Authority
CO
Colombia
Prior art keywords
biomarkers
expression
diagnosis
oral cavity
soft tissue
Prior art date
Application number
CO11126599A
Other languages
English (en)
Spanish (es)
Inventor
Harsh M Trivedi
Tao Xu
Ying Yang
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CO6430490A2 publication Critical patent/CO6430490A2/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56955Bacteria involved in periodontal diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO11126599A 2009-04-01 2011-09-27 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral CO6430490A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01

Publications (1)

Publication Number Publication Date
CO6430490A2 true CO6430490A2 (es) 2012-04-30

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11126599A CO6430490A2 (es) 2009-04-01 2011-09-27 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Country Status (15)

Country Link
US (1) US8753820B2 (https=)
EP (1) EP2414837B1 (https=)
JP (1) JP5643288B2 (https=)
CN (1) CN102549432B (https=)
AR (1) AR076041A1 (https=)
BR (1) BRPI1013184A2 (https=)
CA (1) CA2753718C (https=)
CO (1) CO6430490A2 (https=)
MX (1) MX2011008439A (https=)
MY (1) MY179250A (https=)
RU (1) RU2523383C2 (https=)
SG (1) SG173461A1 (https=)
TW (1) TWI481870B (https=)
WO (1) WO2010115034A2 (https=)
ZA (1) ZA201106056B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405565B (zh) * 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗-骨質流失及抗-牙周附連喪失之功效
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
US20190339269A1 (en) * 2017-01-03 2019-11-07 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
EP3631462A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
JP7245174B2 (ja) * 2017-05-24 2023-03-23 コーニンクレッカ フィリップス エヌ ヴェ 唾液のhgf及びmmp-8に基づく歯周炎の診断
JP7486316B2 (ja) 2017-05-24 2024-05-17 コーニンクレッカ フィリップス エヌ ヴェ 唾液のil-1ベータ及びmmp-9に基づく軽度の又は進行した歯周炎の診断
CN111226118A (zh) 2017-10-27 2020-06-02 加利福尼亚大学董事会 用于牙龈炎的唾液细胞外rna生物标记物
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
JP2000512285A (ja) 1996-06-12 2000-09-19 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 化粧品および/または薬剤製剤
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6696261B2 (en) 1999-12-03 2004-02-24 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
JP2006517969A (ja) 2003-02-14 2006-08-03 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の治療のための組み合わせ療法
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
WO2005039504A2 (en) 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
JP2007519894A (ja) 2003-12-03 2007-07-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ 標的としてのカドヘリンの使用
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
JP4934812B2 (ja) * 2004-12-21 2012-05-23 国立大学法人 奈良先端科学技術大学院大学 Nfat2発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ES2431291T3 (es) 2006-01-10 2013-11-25 Colgate-Palmolive Company Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
JP5643288B2 (ja) 2014-12-17
WO2010115034A3 (en) 2010-12-29
CN102549432B (zh) 2015-03-25
CA2753718C (en) 2015-06-23
JP2012522994A (ja) 2012-09-27
CN102549432A (zh) 2012-07-04
TWI481870B (zh) 2015-04-21
RU2011144032A (ru) 2013-05-10
US8753820B2 (en) 2014-06-17
EP2414837B1 (en) 2015-06-03
BRPI1013184A2 (pt) 2016-04-12
AR076041A1 (es) 2011-05-11
EP2414837A2 (en) 2012-02-08
SG173461A1 (en) 2011-09-29
MY179250A (en) 2020-11-02
TW201102653A (en) 2011-01-16
CA2753718A1 (en) 2010-10-07
MX2011008439A (es) 2011-09-06
ZA201106056B (en) 2015-05-27
US20120028261A1 (en) 2012-02-02
RU2523383C2 (ru) 2014-07-20
AU2010232593A1 (en) 2011-08-25
WO2010115034A2 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
CO6430490A2 (es) Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
DE602006011896D1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
ES2548508T3 (es) Métodos de tratamiento de enfermedades
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
ES2569663T3 (es) Procedimiento de diagnóstico
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
NO20062118L (no) Inhibitor kontrastmidler
EP4523625A4 (en) ELECTRODE DEVICE FOR LIVING BODY
BR112022008886A2 (pt) Diagnóstico de transtornos de humor usando biomarcadores de edição de rna do sangue
WO2010047938A3 (en) Mmp activation peptide detection in biological samples
MY196578A (en) Method for Determining Stage of Periodontal Disease
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
JP2012522994A5 (https=)
NO20076119L (no) Diagnostisk markor for diabetiske vaskulaere komplikasjoner
BR112013003793A2 (pt) método de diagnóstico das doenças neurodegenerativas
DK1756571T3 (da) Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande
EP4426860A4 (en) DIRECT NON-INVASIVE PROTEOMIC PROFILING USING STOOL SAMPLES FOR THE DIAGNOSIS OF GASTROINTESTINAL DISEASES
CY1111602T1 (el) ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ
PL405046A1 (pl) Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
AR076177A1 (es) MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
WO2018236134A3 (en) METHOD AND KIT FOR THE DIAGNOSIS OF MUSCLE WEAK RELATED DISEASES USING A BLOOD BIOMARKER
IL311579A (en) Methods for prognosing type 1 diabetes treatments
UY31535A1 (es) Método para diagnosticar tumores colorrectales
JP2012524884A5 (https=)

Legal Events

Date Code Title Description
FG Application granted